Investigational Study of Delayed Release Metformin

NCT04854512 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

675

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic company decision - not related to a safety concern

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Metformin DR
DRUG: Metformin IR
DRUG: Metformin DR Placebo
DRUG: Metformin IR placebo

Sponsor

Anji Pharma